The forecast for liver malignant neoplasms mortality in the U.S. from 2024 to 2028 indicates a steady increase, with deaths projected to rise from 30.82 to 33.3 thousand. Compared to 2023, where the figure stood at 30.2 thousand, this represents a growth trend. The year-on-year growth rate shows a consistent increase of approximately 2% annually over the two years. The compound annual growth rate (CAGR) over this period suggests a similar annual rise in mortality figures.
Future trends to watch include potential advancements in medical treatment, policy changes impacting healthcare access, and shifts in population demographics that might influence these mortality rates. Monitoring the implementation of early detection programs and overall public health initiatives could also impact these forecasts significantly.
